Adenovirus-transduced human butyrylcholinesterase in mouse blood functions as a bioscavenger of chemical warfare nerve agents

Molecular Pharmacology

Volumn 76, Issue 3, 2009, Pages 612-617

  Chilukuri, Nageswararao ^a   Duysen, Ellen G ^b   Parikh, Kalpana ^a   DiTargiani, Robert ^a   Doctor, Bhupendra P ^a   Lockridge, Oksana ^b   Saxena, Ashima ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CHEMICAL WARFARE AGENT; CHOLINESTERASE; DIMER; ENZYME ANTIBODY; O ETHYL S 2 N,N DIISOPROPYLAMINOETHYLMETHYLPHOSPHONOTHIOLATE; OLIGOMER; RECOMBINANT HUMAN CHOLINESTERASE; SOMAN; TETRAMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; ENZYME ACTIVITY; ENZYME SUBUNIT; FEMALE; HUMAN; HUMAN CELL; MOLECULAR SIZE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOVIRIDAE; ANIMALS; BUTYRYLCHOLINESTERASE; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; HUMANS; MICE; MICE, KNOCKOUT; RECOMBINANT PROTEINS; SOMAN; TISSUE DISTRIBUTION; TRANSDUCTION, GENETIC;

EID: 69549113501     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.055665     Document Type: Article

References (38)

1. Allon N, Raveh L, Gilat E, Cohen E, Grunwald J, and Ashani Y (1998) Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase. Toxicol Sci 43:121-128. (Pubitemid 28363385)
2. Ashani Y and Pistinner S (2004) Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic model. Toxicol Sci 77:358-367. (Pubitemid 38262609)
3. Ashani Y, Shapira S, Levy D, Wolfe AD, Doctor BP, and Raveh L (1991) Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochem Pharmacol 41:37-41.
4. Chilukuri N, Duysen EG, Parikh K, Sun W, Doctor BP, Lockridge O, and Saxena A (2008a) Adenovirus-mediated gene transfer of human butyrylcholinesterase results in persistent high-level transgene expression in vivo. Chem Biol Interact 175:327-331.
5. Chilukuri N, Parikh K, Sun W, Naik R, Tipparaju P, Doctor BP, and Saxena A (2005) Polyethylene glycosylation prolongs the circulatory stability of recombinant human butyrylcholinesterase. Chem Biol Interact 157-158:115-121. (Pubitemid 41757641)
6. Chilukuri N, Sun W, Naik RS, Parikh K, Tang L, Doctor BP, and Saxena A (2008b) Effect of polyethylene glycol modification on the circulatory stability and immunogenicity of recombinant human butyrylcholinesterase. Chem Biol Interact 175:255-260.
7. Chilukuri N, Sun W, Parikh K, Naik RS, Tang L, Doctor BP, and Saxena A (2008c) A repeated injection of polyethyleneglycol-conjugated recombinant human butyrylcholinesterase elicits immune response in mice. Toxicol Appl Pharmacol 231:423-429.
8. Connelly S and Mech C (2004) Delivery of adenoviral vector DNA to mouse liver. Methods Mol Biol 246:37-52.
9. Dacre JC (1984) Toxicology of some anticholinesterases used as chemical warfare agents - a review, in Cholinesterases, Fundamental and Applied Aspects (Brzin M, Barnard EA, and Sket D eds) pp 415-426, de Gruyter, Berlin, Germany.
10. Dai Y, Schwarz EM, Gu D, Zhang WW, Sarvetnick N, and Verma IM (1995) Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci U S A 92:1401-1405.
11. Doctor BP and Saxena A (2005) Bioscavengers for the protection of humans against organophosphate toxicity. Chem Biol Interact 157-158:167-171. (Pubitemid 41757647)
12. Doctor BP, Toker L, Roth E, and Silman I (1987) Microtiter assay for acetylcholinesterase. Anal Biochem 166:399-403.
13. Duysen EG, Bartels CF, and Lockridge O (2002) Wild-type and A328W mutant human butyrylcholinesterase tetramers expressed in Chinese hamster ovary cells have a 16-hour half-life in the circulation and protect mice from cocaine toxicity. J Pharmacol Exp Ther 302:751-758.
14. Ellman GL, Courtney KD, Andres V Jr, and Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95.
15. Gao Y, Atanasova E, Sui N, Pancook JD, Watkins JD, and Brimijoin S (2005) Gene transfer of cocaine hydrolase suppresses cardiovascular responses to cocaine in rats. Mol Pharmacol 67:204-211, 2005. (Pubitemid 40069980)
16. Haupt H, Heide K, Zwisler O, and Schwick HG (1966) Isolation and physico-chemical characterization of cholinesterase in human serum. Blut 14:65-75.
17. Heath AJW and Meredith T (1992) Atropine in the management of anticholinesterase poisoning, in Clinical and Experimental Toxicology of Organophosphates and Carbamates (Ballantyne B and Marrs TC, eds) pp 543-560, Butterworth, Oxford.
18. Huang YJ, Huang Y, Baldassarre H, Wang B, Lazaris A, Leduc M, Bilodeau AS, Bellemare A, Côté M, Herskovits P, et al. (2007) Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning. Proc Natl Acad Sci U S A 104:13603-13608. (Pubitemid 350010655)
19. Karnovsky MJ and Roots L (1964) A "direct-coloring" thiocholine method for cholinesterases. J Histochem Cytochem 12:219-221.
20. Lenz DE, Maxwell DM, Koplovitz I, Clark CR, Capacio BR, Cerasoli DM, Federko JM, Luo C, Saxena A, Doctor BP, et al. (2005) Protection against soman poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys. Chem Biol Interact 157-158:205-210. (Pubitemid 41757652)
21. Li B, Duysen EG, Saunders TL, and Lockridge O (2006) Production of the butyrylcholinesterase knockout mice. J Mol Neurosci 30:193-195.
22. Li H, Schopfer LM, Masson P, and Lockridge O (2008) Lamellipodin proline rich peptides associated with native plasma butyrylcholinesterase tetramers. Biochem J 411:425-432. (Pubitemid 351580195)
23. Lockridge O, Bartels CF, Vaughan TA, Wong CK, Norton SE, and Johnson LL (1987) Complete amino acid sequence of human serum cholinesterase. J Biol Chem 262:549-557. (Pubitemid 17005217)
24. Lockridge O, Eckerson HW, and La Du BN (1979) Interchain disulfide bonds and subunit organization in human serum cholinesterase. J Biol Chem 254:8324-8330.
25. Marrs TC, Maynard RL, and Sidell ER (1996) Riot-control Agents, in Chemical Warfare Agents: Toxicology and Treatment, pp 221-230, John Wiley, Chichester.
26. Marrs TC, Rice P, and Vale JA (2006) The role of oximes in the treatment of nerve agent poisoning in civilian casualties. Toxicol Rev 25:297-323.
27. Okubo Y, Bessho K, Fujimura K, Iizuka T, and Miyatake SI (2000) Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression. Biochem Biophys Res Commun 267:382-387. (Pubitemid 30072560)
28. Raveh L, Grauer E, Grunwald J, Cohen E, and Ashani Y (1997) The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase. Toxicol Appl Pharmacol 145:43-53. (Pubitemid 27294768)
29. Raveh L, Grunwald J, Marcus D, Papier Y, Cohen E, and Ashani Y (1993) Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization. Biochem Pharmacol 45:2465-2474. (Pubitemid 23189540)
30. Saxena A, Ashani Y, Raveh L, Stevenson D, Patel T, and Doctor BP (1998) Role of oligosaccharides in the pharmacokinetics of tissue-derived and genetically engineered cholinesterases. Mol Pharmacol 53:112-122. (Pubitemid 28068378)
31. Saxena A, Sun W, Luo C, and Doctor BP (2005) Human serum butyrylcholinesterase: In vitro and in vivo stability, pharmacokinetics, and safety in mice. Chem Biol Interact 157-158:199-203. (Pubitemid 41757651)
32. Saxena A, Luo C, and Doctor BP (2008) Developing procedures for the large-scale purification of human serum butyrylcholinesterase. Protein Expr Purif 61:191-196.
33. Shah V, Chen AF, Cao S, Hendrickson H, Weiler D, Smith L, Yao J, and Katusic ZS (2000) Gene transfer of recombinant endothelial nitric oxide synthase to liver in vivo and in vitro. Am J Physiol Gastrointest Liver Physiol 279:G1023-G1030.
34. Sidell FR (1997) Nerve agents, in Medical Aspects of Chemical and Biological Warfare (Textbook of Military Medicine. Part 1, Warfare, Weaponry, and the Casualty, vol. 3.) (Sidell FR, Takafuji ET, and Franz DR eds) pp 129-179, Office of the Surgeon General, Department of the Army, Washington, DC.
35. Taylor P (1990) Anticholinesterase agents, in The Pharmacological Basis of Therapeutics (Gilman AG, Rall TW, Nies AS, and Taylor P eds) pp 131-149, Macmillan, New York.
36. Walther W and Stein U (2000) Viral vectors for gene transfer: a review of their use in the treatment of human diseases. Drugs 60:249-271. (Pubitemid 30680387)
37. Yang Y, Ertl HC, and Wilson JM (1994) MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433-442. (Pubitemid 2134473)
38. Yang Y, Li Q, Ertl HC, and Wilson JM (1995) Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 69:2004-2015.